HCV/HIV co-infected patients exhibit higher circulating HCV RNA in peripheral blood [8]–[10], reduced rate of spontaneous resolution of HCV infection [11], [12] and lower responsiveness (up to 30%) to IFN-based therapy [13], [14]. Here, IFNA1 is linked to infection.